Skip to content
PubMed This is a summary of 12 peer-reviewed journal articles Updated
Dermatology

What is the Link Between CCCA and Uterine Fibroids?

At a Glance

Current research has not proved that CCCA causes uterine fibroids or consistently increases fibroid risk. Routine pelvic ultrasound is not recommended solely for CCCA, but abnormal bleeding, pelvic pain, or anemia symptoms should be evaluated.

While you may have heard that Central Centrifugal Cicatricial Alopecia (CCCA)—a type of permanent, scarring hair loss that usually starts at the center of the scalp—is linked to uterine fibroids (noncancerous growths in the uterus), the current medical evidence shows a possible connection but not a proven cause-and-effect relationship. Some research suggests that people with CCCA might have a higher chance of also having uterine fibroids, but other studies have found no increased risk at all [1][2]. Because both conditions are very common in Black women, experts are still working to understand if they truly share an underlying biological cause or if they simply happen to occur often in the same population.

Bottom Line Summary

  • CCCA does not cause fibroids, and having CCCA does not mean you automatically have them.
  • Research on the link is mixed and inconclusive.
  • You do not need a pelvic ultrasound solely because you have CCCA.
  • You should seek medical evaluation if you develop abnormal bleeding, severe pelvic pain, or signs of anemia.

Understanding the Research on CCCA and Fibroids

The medical community has been investigating whether CCCA and uterine fibroids are linked because researchers hypothesized they might both be “fibroproliferative” conditions—meaning they involve a process of inflammation and excess tissue scarring [3][4]. However, this is just a theory. Direct genetic or molecular evidence linking the two conditions is currently weak, and they do not share a proven biological cause [5].

When looking at the numbers, the research is mixed:

  • Some studies suggest a connection: A 2025 review that combined data from multiple studies estimated that about 28% of people with CCCA also had uterine fibroids [1]. The review found that, on average, the odds of having fibroids were higher in people with CCCA than those without it [1]. However, this 28% is a pooled average from specific study groups, not a prediction of your personal risk, and the results varied widely between the individual studies [1].
  • Other studies show no connection: In contrast, a large study comparing 427 Black women with biopsy-confirmed CCCA (diagnosed by a tissue sample) against 1,281 women without the condition found that the CCCA group was not more likely to have fibroids [2]. Another smaller study also found no meaningful mathematical difference in fibroid rates [6].

It is important to note that uterine fibroids are very common overall, especially among Black women, with estimates suggesting up to 80% may develop them by age 50 [7][8]. Because fibroids are already so prevalent, it makes it challenging for researchers to determine if having CCCA actually increases your risk, or if the two conditions just frequently happen to co-occur in the same demographic [9][10].

What This Means for Your Health

The most important takeaway is that having a CCCA diagnosis does not mean you automatically have or will develop uterine fibroids [1][11].

Because a direct link is not fully established, medical guidelines do not recommend that you get a routine pelvic ultrasound or other imaging just because you have CCCA [1][11]. In fact, many uterine fibroids do not cause any symptoms and require no treatment or further investigation [11]. If fibroids are found, whether they need treatment depends on your symptoms, their size and location, and your pregnancy or fertility goals.

Symptoms to Watch For

While you don’t need automatic testing, you should be aware of your body and monitor for symptoms that might indicate uterine fibroids or other reproductive health conditions. If you experience any of the following, report them to your primary care doctor or gynecologist:

  • Abnormal bleeding: This includes menstrual periods that are unusually heavy, prolonged, irregular, or occur between cycles [7].
  • Postmenopausal bleeding: Any vaginal bleeding after you have gone through menopause always requires prompt medical evaluation [7].
  • Pelvic pain or pressure: A feeling of fullness, bulkiness, or dull pain in your lower abdomen or pelvis [7].
  • Bathroom changes: Needing to urinate frequently or experiencing unexplained constipation [7].

If your doctor suspects you might have fibroids based on your symptoms and a physical examination, an ultrasound is commonly the first step used to see what is going on [12]. They may also recommend a blood test (complete blood count) to check for anemia or a pregnancy test if relevant.

When to Seek Urgent Care

Heavy bleeding and severe pain can sometimes become medical emergencies. Seek urgent or emergency medical care if you experience:

  • Bleeding that soaks through one or more pads or tampons every hour for two or more hours consecutively.
  • Signs of severe blood loss, such as feeling dizzy, lightheaded, unusually weak, short of breath, or fainting.
  • Severe, sudden, or rapidly worsening pelvic pain.
  • Bleeding or pain when there is a possibility you could be pregnant.

Keep a record of your bleeding days, the number of pads or tampons used, pain levels, and any dizziness to share with your clinician. This information is highly valuable for determining the best next steps for your care.

Common questions in this guide

Does CCCA cause uterine fibroids?
No. Current evidence does not show that CCCA causes uterine fibroids, and studies disagree about whether people with CCCA have higher odds of fibroids.
Should I have a pelvic ultrasound because I have CCCA?
Not routinely. A pelvic ultrasound is generally considered when symptoms or an examination suggest fibroids or another pelvic condition, rather than solely because you have CCCA.
What symptoms could point to uterine fibroids?
Possible symptoms include unusually heavy, long, or irregular periods, bleeding between periods, and bleeding after menopause. Pelvic pressure or pain, frequent urination, and constipation can also occur. Heavy bleeding may lead to fatigue, weakness, dizziness, or anemia.
When should fibroid-related bleeding or pain be treated as an emergency?
Seek urgent or emergency care if bleeding soaks at least one pad or tampon each hour for two hours in a row, or if you feel faint, dizzy, unusually weak, or short of breath. Severe, sudden, or worsening pelvic pain, or bleeding or pain when pregnancy is possible, also needs urgent evaluation.
If I have fibroids, could they affect fertility or my treatment options?
Whether fibroids need treatment depends on your symptoms, as well as their size and location and your pregnancy or fertility goals. A gynecologist can use these factors to discuss whether monitoring or treatment is appropriate.
Should heavy periods be checked for anemia?
If your periods become heavy or prolonged, a clinician may order a complete blood count to check for anemia, including low hemoglobin. Share fatigue, weakness, dizziness, shortness of breath, and your bleeding pattern with your clinician.

Questions For You

Answer a question to get research tailored to you. Your answers are private.

Get notified when new evidence is published on Central centrifugal cicatricial alopecia.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Given my CCCA diagnosis and family history, are there any specific pelvic symptoms or menstrual changes I should monitor for?
  2. 2.If my periods become heavy, should we run a complete blood count to check my iron and hemoglobin levels?
  3. 3.What specific symptoms would mean I need to seek same-day or urgent care, versus scheduling a regular appointment?
  4. 4.If I do have fibroids, how would their size and location affect my treatment options or future fertility plans?

References

References (12)
  1. 1

    Systemic Comorbidities in Central Centrifugal Cicatricial Alopecia: A Systematic Review and Meta-analysis.

    Sanz-Cabanillas JL, Gómez-García FJ, Ungar B, et al.

    Acta dermato-venereologica 2026; (106()) doi:10.2340/actadv.v106.adv-2026-0456.

    PMID: 42549602
  2. 2

    Evaluating the association of central centrifugal cicatricial alopecia (CCCA) and fibroproliferative disorders.

    Samrao A, Lyon L, Mirmirani P

    Dermatology online journal 2021; (27(8)) doi:10.5070/D327854688.

    PMID: 34755957
  3. 3

    Fibroproliferative genes are preferentially expressed in central centrifugal cicatricial alopecia.

    Aguh C, Dina Y, Talbot CC, Garza L

    Journal of the American Academy of Dermatology 2018; (79(5)):904-912.e1 doi:10.1016/j.jaad.2018.05.1257.

    PMID: 29913259
  4. 4

    Characterization of the inflammatory features of central centrifugal cicatricial alopecia.

    Flamm A, Moshiri AS, Roche F, et al.

    Journal of cutaneous pathology 2020; (47(6)):530-534 doi:10.1111/cup.13666.

    PMID: 32068905
  5. 5

    Presence of Uterine Leiomyomas Has No Significant Impact on Gene Expression Profile in the Scalp of Patients with Central Centrifugal Cicatricial Alopecia.

    Jamerson TA, Talbot CC, Dina Y, Aguh C

    JID innovations : skin science from molecules to population health 2022; (2(1)):100060 doi:10.1016/j.xjidi.2021.100060.

    PMID: 35024684
  6. 6

    Increased Association between Previous Pregnancies and Use of Chemical Relaxers in 74 Women with Central Centrifugal Cicatricial Alopecia.

    Narasimman M, De Bedout V, Castillo DE, Miteva MI

    International journal of trichology 2020; (12(4)):176-181 doi:10.4103/ijt.ijt_37_20.

    PMID: 33376287
  7. 7

    Epidemiology and management of uterine fibroids.

    Giuliani E, As-Sanie S, Marsh EE

    International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics 2020; (149(1)):3-9 doi:10.1002/ijgo.13102.

    PMID: 31960950
  8. 8

    Uterine fibroids - Causes, impact, treatment, and lens to the African perspective.

    Sefah N, Ndebele S, Prince L, et al.

    Frontiers in pharmacology 2022; (13()):1045783 doi:10.3389/fphar.2022.1045783.

    PMID: 36703761
  9. 9

    A US population-based study of uterine fibroid diagnosis incidence, trends, and prevalence: 2005 through 2014.

    Yu O, Scholes D, Schulze-Rath R, et al.

    American journal of obstetrics and gynecology 2018; (219(6)):591.e1-591.e8 doi:10.1016/j.ajog.2018.09.039.

    PMID: 30291840
  10. 10

    Ultrasound-Confirmed, Age-Specific Uterine Leiomyoma Incidence in a Cohort of Black Individuals.

    Wegienka G, Havstad S, Coleman C, et al.

    Obstetrics and gynecology 2022; (140(6)):1042-1048 doi:10.1097/AOG.0000000000004997.

    PMID: 36357982
  11. 11

    The management of uterine leiomyomas.

    Vilos GA, Allaire C, Laberge PY, et al.

    Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC 2015; (37(2)):157-178 doi:10.1016/S1701-2163(15)30338-8.

    PMID: 25767949
  12. 12

    Diagnosis and classification of uterine fibroids.

    Lakabi R, Harth S, Meinhold-Heerlein I, et al.

    International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics 2025; (171(2)):566-573 doi:10.1002/ijgo.70538.

    PMID: 40970558

This page is for informational purposes only and does not constitute medical advice. It explains the mixed evidence about CCCA and uterine fibroids; a clinician should evaluate your symptoms and decide whether testing is appropriate.